Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Contact
Search
×
Cancer Tissue Gallery TRIM29
Path
Created with Sketch.
Go to TRIM29 Normal Tissue Gallery
Go back to Product Page
Adrenal gland- TRIM29 negative adrenocortical adenoma.
Adrenal gland- TRIM29 negative adrenocortical adenoma.
Adrenal gland- TRIM29 negative pheochromocytoma.
Adrenal gland- TRIM29 negative pheochromocytoma.
Anal canal- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Anal canal- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Breast- TRIM29 negative invasive breast cancer of no special type (NST).
Breast- TRIM29 negative invasive breast cancer of no special type (NST).
Breast- TRIM29 negative invasive lobular breast cancer.
Breast- TRIM29 negative invasive lobular breast cancer.
Colon- Colorectal adenocarcinoma with a moderate to strong TRIM29 positivity of tumor cells.
Colon- Colorectal adenocarcinoma with a moderate to strong TRIM29 positivity of tumor cells.
Esophagus- Adenocarcinoma with strong TRIM29 immunostaining of tumor cells.
Esophagus- Adenocarcinoma with strong TRIM29 immunostaining of tumor cells.
Esophagus- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Esophagus- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Kidney- TRIM29 negative clear cell renal cell carcinoma.
Kidney- TRIM29 negative clear cell renal cell carcinoma.
Larynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Larynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Liver- TRIM29 negative hepatocellular carcinoma.
Liver- TRIM29 negative hepatocellular carcinoma.
Lung- Adenocarcinoma with moderate to strong TRIM29 immunostaining of tumor cells.
Lung- Adenocarcinoma with moderate to strong TRIM29 immunostaining of tumor cells.
Lung- Malignant mesothelioma with strong TRIM29 immunostaining of >50% of tumor cells.
Lung- Malignant mesothelioma with strong TRIM29 immunostaining of >50% of tumor cells.
Lung- TRIM29 negative adenocarcinoma.
Lung- TRIM29 negative adenocarcinoma.
Lung- TRIM29 negative small cell carcinoma.
Lung- TRIM29 negative small cell carcinoma.
Ovary- Brenner tumor with strong TRIM29 immunostaining of epithelial tumor cell nests.
Ovary- Brenner tumor with strong TRIM29 immunostaining of epithelial tumor cell nests.
Ovary- Endometroid carcinoma with weak to moderate, membranous TRIM29 immunostaining of about 50% of tumor cells.
Ovary- Endometroid carcinoma with weak to moderate, membranous TRIM29 immunostaining of about 50% of tumor cells.
Ovary- Mucinous carcinoma with weak to moderate TRIM29 immunostaining of the majority of tumor cells.
Ovary- Mucinous carcinoma with weak to moderate TRIM29 immunostaining of the majority of tumor cells.
Ovary- Serous high-grade carcinoma with a moderate TRIM29 immunostaining of luminal membranes of tumor cells.
Ovary- Serous high-grade carcinoma with a moderate TRIM29 immunostaining of luminal membranes of tumor cells.
Pancreas- Ductal adenocarcinoma with strong TRIM29 immunostaining of tumor cells.
Pancreas- Ductal adenocarcinoma with strong TRIM29 immunostaining of tumor cells.
Pancreas- TRIM29 negative acinar cell carcinoma.
Pancreas- TRIM29 negative acinar cell carcinoma.
Pancreas- TRIM29 negative neuroendocrine tumor.
Pancreas- TRIM29 negative neuroendocrine tumor.
Penis- Squamous cell carcinoma with strong TRIM29 positivity of tumor cells.
Penis- Squamous cell carcinoma with strong TRIM29 positivity of tumor cells.
Pharynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Pharynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Prostate- TRIM29 negative adenocarcinoma (Gleason 3+3=6).
Prostate- TRIM29 negative adenocarcinoma (Gleason 3+3=6).
Salivary gland- Warthin tumor with weak to moderate, membranous TRIM29 immunostaining, mainly of the basal cell layers and of luminal membranes.
Salivary gland- Warthin tumor with weak to moderate, membranous TRIM29 immunostaining, mainly of the basal cell layers and of luminal membranes.
Skin- Basal cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Skin- Basal cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Skin- TRIM29 negative malignant melanoma.
Skin- TRIM29 negative malignant melanoma.
Soft tissue- TRIM29 negative leiomyosarcoma.
Soft tissue- TRIM29 negative leiomyosarcoma.
Stomach- Adenocarcinoma with moderate membranous TRIM29 positivity of tumor cells.
Stomach- Adenocarcinoma with moderate membranous TRIM29 positivity of tumor cells.
Stomach- TRIM29 negative gastrointestinal stromal tumor (GIST).
Stomach- TRIM29 negative gastrointestinal stromal tumor (GIST).
Testis- TRIM29 negative Leydig cell tumor.
Testis- TRIM29 negative Leydig cell tumor.
Testis- TRIM29 negative seminoma.
Testis- TRIM29 negative seminoma.
Thyroid- TRIM29 negative medullary carcinoma.
Thyroid- TRIM29 negative medullary carcinoma.
Thyroid- TRIM29 negative papillary carcinoma.
Thyroid- TRIM29 negative papillary carcinoma.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Sarkomatoid carcinoma with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Sarkomatoid carcinoma with strong TRIM29 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.